Reset filters
  • 9 March 2006

Genotypic resistance testing on a failing regimen is possible below 1000 copies/ml

Read the article
  • 8 February 2006

CROI: Atazanavir/ritonavir joins other boosted PIs as potential single-class maintenance regimen

Read the article
  • 7 February 2006

CROI: Simplified treatment regimens show promise in HIV-infected children

Read the article
  • 19 January 2006

Almost a third of Indian patients make changes to first-line treatment regimen because of side-effects or cost

Read the article
  • 13 January 2006

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

Read the article
  • 12 January 2006

ICAAC: Switching from Combivir to Truvada has benefits for treatment-experienced patients

Read the article
  • 28 November 2005

OK study continues to show potency of Kaletra monotherapy after 72 weeks

Read the article
  • 22 November 2005

Patients switching from other PIs to unboosted atazanavir maintain viral suppression

Read the article
  • 21 October 2005

Side-effects major reason UK patients switch from first-line therapy, BHIVA audit finds

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.